MIF and ulcerative colitis: Of note, MIF could also be a therapeutic target in a number of immune-related pathologies such as asthma [26], rheumatoid arthritis [27], chronic colitis [28], ulcerative colitis [29], glomerulonephritis [30], and lupus erythematosus [31], highlighting the possible clinical significance of the present study.